特刊征稿：乙型肝炎病毒：攻克古老疾病的新突破
Special Issue "Hepatitis B Virus: New Breakthroughs to Conquer an Ancient Disease".
机构信息
Storr Liver Centre, Westmead Institute for Medical Research, University of Sydney and Westmead Hospital, Westmead, NSW 2145, Australia.
Sydney Infectious Diseases Institute, University of Sydney and Westmead Hospital, Westmead, NSW 2145, Australia.
出版信息
Viruses. 2023 Oct 30;15(11):2173. doi: 10.3390/v15112173.
Abstract
Chronic hepatitis B affects >300 million people worldwide and is a major cause of liver disease, causing ~800,000 deaths each year [...].
摘要
全球有超过 3 亿人患有慢性乙型肝炎，是肝病的主要病因，每年导致约 80 万人死亡[... ]。
相似文献
1
Special Issue "Hepatitis B Virus: New Breakthroughs to Conquer an Ancient Disease".
Viruses. 2023 Oct 30;15(11):2173. doi: 10.3390/v15112173.
2
Test All for Hepatitis B Virus: Link to Care and Treatment if Quantitative DNA Positive, Vaccinate if Susceptible.
Clin Liver Dis. 2023 Nov;27(4):997-1022. doi: 10.1016/j.cld.2023.05.009. Epub 2023 Jul 7.
3
The interplay of long noncoding RNAs and hepatitis B virus.
J Med Virol. 2023 Jan;95(1):e28058. doi: 10.1002/jmv.28058. Epub 2022 Aug 23.
4
Viral hepatitis B.
Lancet. 2003 Dec 20;362(9401):2089-94. doi: 10.1016/S0140-6736(03)15108-2.
5
Human immune repertoire in hepatitis B virus infection.
World J Gastroenterol. 2021 Jul 7;27(25):3790-3801. doi: 10.3748/wjg.v27.i25.3790.
6
Hepatitis B today.
Hepatogastroenterology. 2007 Mar;54(74):545-8.
7
Establishment of cell culture model and humanized mouse model of chronic hepatitis B virus infection.
Microbiol Spectr. 2024 Jan 11;12(1):e0274523. doi: 10.1128/spectrum.02745-23. Epub 2023 Nov 29.
8
Surrogate Markers for Hepatitis B Virus Covalently Closed Circular DNA.
Semin Liver Dis. 2022 Aug;42(3):327-340. doi: 10.1055/a-1830-2741. Epub 2022 Apr 20.
9
Hepatitis B vaccines: protective efficacy and therapeutic potential.
Pathol Biol (Paris). 2010 Aug;58(4):288-95. doi: 10.1016/j.patbio.2010.01.006. Epub 2010 Apr 10.
10
Hepatitis B virus infection: understanding its epidemiology, course, and diagnosis.
Cleve Clin J Med. 2008 Dec;75(12):881-9. doi: 10.3949/ccjm.75a.07019.
本文引用的文献
1
Optimized ex vivo stimulation identifies multi-functional HBV-specific T cells in a majority of chronic hepatitis B patients.
Sci Rep. 2020 Jul 9;10(1):11344. doi: 10.1038/s41598-020-68226-5.
2
The Lived Experience of Chronic Hepatitis B: A Broader View of Its Impacts and Why We Need a Cure.
Viruses. 2020 May 7;12(5):515. doi: 10.3390/v12050515.
3
A global scientific strategy to cure hepatitis B.
Lancet Gastroenterol Hepatol. 2019 Jul;4(7):545-558. doi: 10.1016/S2468-1253(19)30119-0. Epub 2019 Apr 10.
4
Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study.
Lancet Gastroenterol Hepatol. 2018 Jun;3(6):383-403. doi: 10.1016/S2468-1253(18)30056-6. Epub 2018 Mar 27.
5
A research agenda for curing chronic hepatitis B virus infection.
Hepatology. 2018 Mar;67(3):1127-1131. doi: 10.1002/hep.29509. Epub 2018 Jan 24.
6
Requirements for global elimination of hepatitis B: a modelling study.
Lancet Infect Dis. 2016 Dec;16(12):1399-1408. doi: 10.1016/S1473-3099(16)30204-3. Epub 2016 Sep 13.
7
Entecavir treatment does not eliminate the risk of hepatocellular carcinoma in chronic hepatitis B: limited role for risk scores in Caucasians.
Gut. 2015 Aug;64(8):1289-95. doi: 10.1136/gutjnl-2014-307023. Epub 2014 Jul 10.
Zotero 插件